NAGENDRAN SUKUMAR sold 26.9% of their position (370.17K shares) of TAYSHA GENE THERAPIES, INC. on the open market
Open‑market sale worth $1.70M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+70.17K
Price / share
$0.70
Trade value
$49.04K
% of position
Common Stock
Shares
+39.95K
Price / share
$1.71
Trade value
$68.32K
% of position
Common Stock
Shares
−110.13K
Price / share
$4.75
Trade value
$523.09K
% of position
Common Stock
Shares
+260.05K
Price / share
$1.71
Trade value
$444.68K
% of position
Common Stock
Shares
−260.05K
Price / share
$4.51
Trade value
$1.17M
% of position
Net shares
+0.00
Net value
-$1.13M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/28/2025 | M · Option Exercise | +70.17K | $0.70 | $49.04K | 7.0% | 1.01M | 1.08M |
| Common Stock Direct | 11/28/2025 | M · Option Exercise | +39.95K | $1.71 | $68.32K | 3.7% | 1.08M | 1.12M |
| Common Stock Direct | 11/28/2025 | S · Sale | −110.13K | $4.75 | $523.09K | 9.9% | 1.12M | 1.01M |
| Common Stock Direct | 12/1/2025 | M · Option Exercise | +260.05K | $1.71 | $444.68K | 25.8% | 1.01M | 1.27M |
| Common Stock Direct | 12/1/2025 | S · Sale | −260.05K | $4.51 | $1.17M | 20.5% | 1.27M | 1.01M |
| Total | +0.00 | -$1.13M | ||||||
Employee Stock Option (right to buy)
Common Stock
70.17K shares
Shares
−70.17K
Strike price
0.6989
Held after
222.68K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
39.95K shares
Shares
−39.95K
Strike price
1.71
Held after
823.66K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
260.05K shares
Shares
−260.05K
Strike price
1.71
Held after
563.62K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock70.17K shares | 11/28/2025 | M · Option Exercise | −70.17K | 0.6989 | — | 222.68K |
| Employee Stock Option (right to buy) Direct | Common Stock39.95K shares | 11/28/2025 | M · Option Exercise | −39.95K | 1.71 | — | 823.66K |
| Employee Stock Option (right to buy) Direct | Common Stock260.05K shares | 12/1/2025 | M · Option Exercise | −260.05K | 1.71 | — | 563.62K |